[1]
K. Introntakun, “A Study on the Incidence of Adverse Reactions and the Severity of Hypersensitivity in Cancer Patients Receiving Taxane-based Chemotherapy at Vajira Hospital”, J DMS, vol. 51, no. 2, pp. 110–118, Jun. 2026.